Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43d5d2dd56ea16effd26945181f84e23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ed69629294ae2b589aa576b56941355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2848 |
filingDate |
2008-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df656e134009aa8b8197d16521afc1ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe9c9a4783444e8073c7b14812b3f83 |
publicationDate |
2009-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009070753-A2 |
titleOfInvention |
Bivalent single chain fv antibody compositions that specifically bind to integrin receptor on a metastatic cell in a mammalian subject |
abstract |
Isolated bivalent single chain Fv antibody compositions and pharmaceutical compositions thereof are provided having affinity for a tumor cell target wherein the tumor cell has a metastatic phenotype. The antibody compositions are provided that specifically bind to an αvβ3 integrin receptor on the metastatic cell. |
priorityDate |
2007-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |